I agree woofs and your prices are conservative despite blackmarango's protestations. If you watch biotech you know that corporations like Janssen and Janssen will not blink at a valuation FAR above $20 if it means a little more certainty about the outcome. GLTA longs.
I would like to see a Biotime merger also, Tony (or Geron).
When uncertainty is removed retail investors will no longer be able to afford this stock, and/or Geron will be part of Janssen and Janssen.
I'm buying now. But thanks for your fear, uncertainty, and doubt.
You got this right, jack:
"I suspect that many of the short shares might just be a hedge for some of the institutional investors just in case there are problems. I think it's only a matter of time before imetelstat meets FDA approval, and it will be shorter than a normal process..."
It's just up to us to use our time wisely.